May 8th 2025, 8:00pm
Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements in high-smoking U.S. regions.
May 8th 2025, 7:00pm
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.
May 8th 2025, 5:01pm
I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, laughter and a community of hope.
May 8th 2025, 4:46pm
Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian cancer with KRAS mutations.
May 8th 2025, 3:00pm
Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.
May 8th 2025, 1:00pm
Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their diagnosis.
May 7th 2025, 9:00pm
This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.
May 7th 2025, 8:14pm
Lung cancer remains the leading cause of cancer-related deaths in the U.S.
May 7th 2025, 8:08pm
LCI has appointed Neal Ready, MD, PhD, as its first Chief Scientific Officer.
May 7th 2025, 8:00pm
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
FDA Designates MB-105 to Speed Review for Relapsed T-Cell Lymphoma
Lymphoma Survivor Discusses the Importance of Finding Humor in Cancer
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis